StocksRegeneron PharmaceuticalsREGN

REGN

Regeneron Pharmaceuticals

635.64 -12.65 (-1.95%)
Delayed Prices By NASDAQ, in USD Market Closed
Trade
S
635.63
B
637.05
Top
Atiq Ur Rehman
Medicare is poised to renegotiate the prices of some of its most expensive drugs through a historic expansion of its power, which could reduce costs for many seniors as well as federal spending on its prescription drug plan. Though difficult to quantify at this stage, however, there will be headwinds... Show More
Fabian Hermans
$REGN (Regeneron Pharmaceuticals) This month, Regeneron completed the purchase of Sanofi's interest in Libtayo. Regeneron paid Sanofi $900 million in cash plus royalties on future payments based on the success of Libtayo. In 2015, Regeneron entered into a licensing and collaboration agreement in... Show More
REGN
Regeneron Pharmaceuticals
635.63
-12.65 (-1.95%)
Trade
Andrea Aldea
⭐ ADA.DIVIDENDS PORTFOLIO – MARKET SUM ⭐ 𝐖𝐡𝐚𝐭 𝐡𝐚𝐩𝐩𝐞𝐧𝐞𝐝 𝐲𝐞𝐬𝐭𝐞𝐫𝐝𝐚𝐲 𝐀𝐮𝐠𝐮𝐬𝐭 𝟖? 🎯 U.S. equities lost morning gains and ended mixed and flat as a new batch of corporate earnings reports raised concerns about economic growth. 🎯 Nvidia $NVDA (NVIDIA Corporation) shares dropped... Show More Translate